Competing Risk Analysis in a Large Cardiovascular Clinical Trial: An APEX Substudy

By Douglas Arbetter, MPH

Competing risk analysis methods present a new way to understand how an event could minimize the chance that a subject will reach the desired endpoint necessary for a clinical trial.

Learn how this analysis is implemented in a cardiovascular trial, and whether it can be assimilated into other similar clinical trials in the future.

Explore Our Key Related Services